ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

External validation of the SORG machine learning algorithms for predicting 90-day and 1-year survival of patients with lung cancer-derived spine metastases: a recent bi-center cohort from China

Zhong, Guoqing; Cheng, Shi; Zhou, Maolin; Xie, Juning; Xu, Ziyang; Lai, Huahao; Yan, Yuan; Xie, Zhenyan; Zhou, Jielong; Xie, Xiaohong; Zhou, Chengzhi; Zhang, Yu*广东省人民医院; 广州医学院; 南方医科大学; 1; y
Spine Journal2023-5DOI: 10.1016/j.spinee.2023.01.008
3被引3阅读
引用收藏
分享

摘要

BACKGROUND CONTEXT: The survival prediction of lung cancer-derived spinal metastases is often underestimated by several scores. The SORG machine learning (ML) algorithm is considered a promising tool to predict the risk of 90-day and 1-year mortality in patients with spinal metasta-ses, but not been externally validated for lung cancer. PURPOSE: This study aimed to externally validate the SORG ML algorithms on lung cancer-derived spinal metastases patients from two large-volume, tertiary medical centers between 2018 and 2021. STUDY DESIGN/SETTING: Retrospective, cohort study. PATIENT SAMPLE: Patients aged 18 years or older at two tertiary medical centers in China are treated surgically for spinal metastasis. OUTCOME MEASURES: Mortality within 90 days of surgery, mortality within 1 year of surgery. METHODS: The baseline characteristics were compared between the development cohort and our validation cohort. Discrimination (receiver operating curve), calibration (calibration plot, intercept, and slope), the overall performance (Brier score), and decision curve analysis was used to assess the overall performance of the SORG ML algorithms. RESULTS: This study included 150 patients with lung cancer-derived spinal metastases from two medical centers in China. Ninety-day and 1-year mortality rates were 12.9% (19/147) and 51.3% (60/117), respectively. Lung Cancer with targeted therapies had the lowest Hazard Ratio (HR=0.490), showing an optimal protecting factor. The AUC of the SORG ML algorithm for 90-day mortality prediction in lung cancer-derived spinal metastases is 0.714. While the AUC for 1-year mortality prediction is 0.832 (95CI%, 0.758-0.906). The algorithm for 1-year mortality was well-calibrated with an intercept of 0.13 and a calibration slope of 1.00. However, the 90-day mor-tality prediction was underestimated with an intercept of 0.60 and a slope of 0.37. The SORG ML algorithms for 1-year mortality showed a greater net benefit than the "treats all or no patients" strategies. CONCLUSIONS: In the latest cohort of lung cancer-derived spinal metastases in China, the SORG algorithms for predicting 1-year mortality performed well on external validation. However, 90-day mortality was underestimated. The algorithm should be further validated by single primary tumor-derived metastasis treated with the latest comprehensive treatment in diverse populations.

学科与关键词

关键词
External validationLung cancerPredictionSpine metastasesSurvival
相关
加载中…
  • Comparing the Accuracy of Seven Scoring Systems in Predicting Survival of Lung Cancer Patients With Spinal Metastases An External Validation From Two Centers
    Yan, Yuan; Zhong, Guoqing; Lai, Huahao; Huang, Chongquan; Yao, Mengyu; Zhou, Maolin; Zhou, Chengzhi; Wang, Jing; Cheng, Shi; Zhang, Yu*Spine, 2023, 48(14): 1009-1016.
  • Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients
    Cui, Yunpeng; Shi, Xuedong*; Wang, Shengjie; Qin, Yong*; Wang, Bailin; Che, Xiaotong; Lei, Mingxing*Frontiers in Public Health, 2022, 10: 1019168.被引 8
  • Predictive Modeling for Spinal Metastatic Disease
    Shah, Akash A.*; Schwab, Joseph H.Diagnostics, 2024, 14(9): 962.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Spine Journal
发表日期
2023-05
卷期
第 23 卷, 第 5 期
页码
731-738
DOI
10.1016/j.spinee.2023.01.008
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [U21A2084]

作者

  • Z

    Zhong, Guoqing (第一作者)

    2 · southern med univ · guangdong prov peoples hosp

  • C

    Cheng, Shi

    guangdong prov peoples hosp · southern med univ

查看全部 12 位作者收起作者
  • Z

    Zhou, Maolin

    1 · guangzhou med univ

  • X

    Xie, Juning

    guangdong prov peoples hosp · southern med univ

  • X

    Xu, Ziyang

    guangdong prov peoples hosp · southern med univ

  • L

    Lai, Huahao

    guangdong prov peoples hosp · southern med univ

  • Y

    Yan, Yuan

    guangdong prov peoples hosp · southern med univ

  • X

    Xie, Zhenyan

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhou, Jielong

    guangdong prov peoples hosp · southern med univ

  • X

    Xie, Xiaohong

    1 · guangzhou med univ

  • Z

    Zhou, Chengzhi

    1 · guangzhou med univ

  • Z

    Zhang, Yu (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417